Jörg F. Rippmann

828 total citations
21 papers, 642 citations indexed

About

Jörg F. Rippmann is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Jörg F. Rippmann has authored 21 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Epidemiology and 7 papers in Hepatology. Recurrent topics in Jörg F. Rippmann's work include Liver Disease Diagnosis and Treatment (7 papers), Liver physiology and pathology (6 papers) and Peptidase Inhibition and Analysis (4 papers). Jörg F. Rippmann is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Liver physiology and pathology (6 papers) and Peptidase Inhibition and Analysis (4 papers). Jörg F. Rippmann collaborates with scholars based in Germany, United States and Netherlands. Jörg F. Rippmann's co-authors include Andreas Schnapp, Hans Bernhard Schmid, Bradford S. Hamilton, Moh Tadayyon, Klaus Damm, Wolfgang J. Rettig, Silke Hobbie, A. Schnapp, Pilar Garin‐Chesa and Herbert Nar and has published in prestigious journals such as PLoS ONE, Journal of Molecular Biology and Applied and Environmental Microbiology.

In The Last Decade

Jörg F. Rippmann

21 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jörg F. Rippmann Germany	15	372	169	157	102	91	21	642
Meital Charni‐Natan Israel	10	347 0.9×	153 0.9×	131 0.8×	81 0.8×	57 0.6×	16	652
Irina Tikhanovich United States	17	517 1.4×	105 0.6×	217 1.4×	110 1.1×	35 0.4×	32	834
Frédérique Bulle France	14	389 1.0×	107 0.6×	123 0.8×	63 0.6×	64 0.7×	26	723
Scott Thomson United Kingdom	11	482 1.3×	100 0.6×	88 0.6×	220 2.2×	71 0.8×	13	1.0k
Keane K. Y. Lai United States	16	344 0.9×	125 0.7×	264 1.7×	55 0.5×	51 0.6×	25	741
Martin Bopst Switzerland	9	207 0.6×	98 0.6×	99 0.6×	201 2.0×	68 0.7×	14	599
Anna Tutusaus Spain	13	285 0.8×	72 0.4×	151 1.0×	189 1.9×	62 0.7×	22	702
Ki Cheong Park South Korea	16	360 1.0×	190 1.1×	113 0.7×	93 0.9×	23 0.3×	36	666
Zhao Tang China	14	269 0.7×	122 0.7×	83 0.5×	96 0.9×	54 0.6×	37	626

Countries citing papers authored by Jörg F. Rippmann

Since Specialization

Citations

This map shows the geographic impact of Jörg F. Rippmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg F. Rippmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg F. Rippmann more than expected).

Fields of papers citing papers by Jörg F. Rippmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörg F. Rippmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg F. Rippmann. The network helps show where Jörg F. Rippmann may publish in the future.

Co-authorship network of co-authors of Jörg F. Rippmann

This figure shows the co-authorship network connecting the top 25 collaborators of Jörg F. Rippmann. A scholar is included among the top collaborators of Jörg F. Rippmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörg F. Rippmann. Jörg F. Rippmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Steixner-Kumar, Agnes A., Jörg F. Rippmann, Tanja Schönberger, et al.. (2024). Diverse potential of secretome from natural killer cells and monocyte-derived macrophages in activating stellate cells. Frontiers in Immunology. 15. 1232070–1232070. 6 indexed citations

Chen, Jennifer Y., Cheng Sun, Lorena Pantano, et al.. (2022). Nanchangmycin regulates FYN, PTK2, and MAPK1/3 to control the fibrotic activity of human hepatic stellate cells. eLife. 11. 8 indexed citations

Pantano, Lorena, Yang Shen, Zhu Zhuo, et al.. (2021). Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD. Scientific Reports. 11(1). 18045–18045. 55 indexed citations

Oldenburger, Anouk, Gerald Birk, Andre Broermann, et al.. (2021). Modulation of vascular contraction via soluble guanylate cyclase signaling in a novel ex vivo method using rat precision‐cut liver slices. Pharmacology Research & Perspectives. 9(3). e00768–e00768. 5 indexed citations

Rydzik, Anna M., et al.. (2020). Epigenetic Modification 6‐Methyladenosine Can Impact the Potency and Specificity of siRNA. ChemBioChem. 22(3). 491–495. 10 indexed citations

Bigaeva, Emilia, Eric J. Simon, Matthias Zwick, et al.. (2019). Transcriptomic characterization of culture-associated changes in murine and human precision-cut tissue slices. Archives of Toxicology. 93(12). 3549–3583. 26 indexed citations

Bigaeva, Emilia, Anouk Oldenburger, Yong Oock Kim, et al.. (2019). PI3K inhibition reduces murine and human liver fibrogenesis in precision-cut liver slices. Biochemical Pharmacology. 169. 113633–113633. 18 indexed citations

Tølbøl, K.S., Birgit Stierstorfer, Jörg F. Rippmann, et al.. (2018). Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic Steatohepatitis. Digestive Diseases and Sciences. 64(5). 1238–1256. 18 indexed citations

Reichetzeder, Christoph, Karoline von Websky, Oleg Tsuprykov, et al.. (2017). Head‐to‐head comparison of structurally unrelated dipeptidyl peptidase 4 inhibitors in the setting of renal ischemia reperfusion injury. British Journal of Pharmacology. 174(14). 2273–2286. 24 indexed citations

10.

Schumacher, Frances‐Rose, Steffen Schubert, Michael Hannus, et al.. (2016). RNAi Screen for NRF2 Inducers Identifies Targets That Rescue Primary Lung Epithelial Cells from Cigarette Smoke Induced Radical Stress. PLoS ONE. 11(11). e0166352–e0166352. 4 indexed citations

11.

Sanderson, Michael P., et al.. (2009). Comparison of the anti-allergic activity of Syk inhibitors with optimized Syk siRNAs in FcεRI-activated RBL-2H3 basophilic cells. Cellular Immunology. 262(1). 28–34. 18 indexed citations

12.

Baum, Patrick, Katrin Fundel‐Clemens, Sebastian Kreuz, et al.. (2009). Off-Target Analysis of Control siRNA Molecules Reveals Important Differences in the Cytokine Profile and Inflammation Response of Human Fibroblasts. Oligonucleotides. 20(1). 17–26. 17 indexed citations

13.

Kreuz, Sebastian, Corinna Schoelch, Leo Thomas, et al.. (2009). Acetyl‐CoA carboxylases 1 and 2 show distinct expression patterns in rats and humans and alterations in obesity and diabetes. Diabetes/Metabolism Research and Reviews. 25(6). 577–586. 29 indexed citations

14.

Schmid, Hans Bernhard, Jörg F. Rippmann, Moh Tadayyon, & Bradford S. Hamilton. (2005). Inhibition of fatty acid synthase prevents preadipocyte differentiation. Biochemical and Biophysical Research Communications. 328(4). 1073–1082. 119 indexed citations

15.

Rippmann, Jörg F., Andreas Schnapp, Andreas Weith, & Silke Hobbie. (2004). Gene silencing with STAT6 specific siRNAs blocks eotaxin release in IL‐4/TNFα stimulated human epithelial cells. FEBS Letters. 579(1). 173–178. 18 indexed citations

16.

Rippmann, Jörg F., Klaus Damm, & Andreas Schnapp. (2002). Functional Characterization of the Poly(ADP-ribose) Polymerase Activity of Tankyrase 1, a Potential Regulator of Telomere Length. Journal of Molecular Biology. 323(2). 217–224. 76 indexed citations

17.

Schmidt, Alexej, Jörg F. Rippmann, Bodo Brocks, et al.. (2001). Human antibody derivatives against the fibroblast activation protein for tumor stroma targeting of carcinomas. International Journal of Cancer. 92(2). 240–248. 1 indexed citations

18.

Rippmann, Jörg F., Klaus Pfizenmaier, Ralf Mattes, Wolfgang J. Rettig, & Dieter Moosmayer. (2000). Fusion of the tissue factor extracellular domain to a tumour stroma specific single-chain fragment variable antibody results in an antigen-specific coagulation-promoting molecule. Biochemical Journal. 349(3). 805–812. 14 indexed citations

19.

Rippmann, Jörg F., Silke Hobbie, Markus Bauer, et al.. (2000). Phosphorylation-dependent proline isomerization catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis.. PubMed. 11(7). 409–16. 111 indexed citations

20.

Rippmann, Jörg F., Christian Hoischen, Bodo Brocks, et al.. (1998). Procaryotic Expression of Single-Chain Variable-Fragment (scFv) Antibodies: Secretion in L-Form Cells of Proteus mirabilis Leads to Active Product and Overcomes the Limitations of Periplasmic Expression in Escherichia coli. Applied and Environmental Microbiology. 64(12). 4862–4869. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact